More than ever, Democratic presidential hopefuls want to take on pharma. Here’s how they’d do it

first_imgPolitics Log In | Learn More GET STARTED Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+. First 30 days free. GET STARTED About the Author Reprints STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. @levfacher What is it? Democratic presidential candidates at a debate in June in Miami. Drew Angerer/Getty Images Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.center_img Tags campaignsdrug pricingpolicyWhite House By Lev Facher Nov. 11, 2019 Reprints [email protected] Washington Correspondent Lev Facher covers the politics of health and life sciences. What’s included? The post below is adapted from a STAT Report, “Democrats and drug pricing,” a deeply reported examination of how the 2020 presidential candidates could reshape the pharmaceutical industry. You can access the full version here. President Trump has made drug pricing a key policy tenet of his three-year tenure in the White House. And as his drug pricing policy has grown more aggressive in the past year, his Democratic challengers in the 2020 election have responded in kind. Lev Facher More than ever, Democratic presidential hopefuls want to take on pharma. Here’s how they’d do it last_img read more

Read More